Vancomycin prescription in neonates and young infants: Toward a simplified dosage

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 5, 2011, Pages

  Oudin, C ^a   Vialet, Renaud ^a   Boulamery, A ^b   Martin, C ^a   Simon, N ^b  

^a HÔPITAL NORD   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VANCOMYCIN;

ARTICLE; CHILD HEALTH CARE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; HUMAN; INFANT; LOADING DRUG DOSE; MEDICATION ERROR; NEPHROTOXICITY; NEWBORN; PRESCRIPTION; PRIORITY JOURNAL; SIMULATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CREATININE; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG PRESCRIPTIONS; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE, NEONATAL; MEDICATION ERRORS; VANCOMYCIN;

EID: 80051784208     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2010.196402     Document Type: Article

References (26)

1. Kimura T., Sunakawa K., Matsuura N., et al. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates. Antimicrob Agents Chemother 2004;48:1159-1167 (Pubitemid 38405469)
2. Anderson B.J., Allegaert K., Van den Anker J.N., et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2007;63:75-84. (Pubitemid 44902880)
3. de Hoog M., Schoemaker R.C., Mouton J.W., et al. Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther 2000;67:360-367 (Pubitemid 30246811)
4. Grimsley C., Thomson A.H. Pharmacokinetics and dose requirements of vancomycin in neonates. Arch Dis Child Fetal Neonatal Ed 1999;81:F221-F227 (Pubitemid 29503334)
5. de Hoog M., Mouton J.W., van den Anker J.N. Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet 2004;43:417-440 (Pubitemid 38716502)
6. Seay R.E., Brundage R.C., Jensen P.D., et al. Population pharmacokinetics of vancomycin in neonates. Clin Pharmacol Ther 1994;56:169-175 (Pubitemid 24274183)
7. McDougal A., Ling E.W., Levine M. Vancomycin pharmacokinetics and dosing in premature neonates. Ther Drug Monit 1995;17:319-326
8. Lo Y.L., van Hasselt J.G., Heng S.C., et al. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination. Antimicrob Agents Chemother 2010;54:2626-2632
9. Silva R., Reis E., Bispo M.A., et al. The kinetic profile of vancomycin in neonates. J Pharm Pharmacol 1998;50:1255-1260 (Pubitemid 28546602)
10. Pawlotsky F., Thomas A., Kergueris M.F., et al. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule. Br J Clin Pharmacol 1998;46:163-167 (Pubitemid 28342788)
11. Plan O., Cambonie G., Barbotte E., et al. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule. Arch Dis Child Fetal Neonatal Ed 2008;93:F418-F421
12. Beal S., Sheiner ME NONMEM Project Group San Francisco, CA: University of California, 1991. http://c255.ucsf.edu/nonmem0.html (accessed 5 March 2010).
13. Boeckmann A., Sheiner L., Beal S NONMEM Users Guide - Part V San Francisco, CA: University of California, 1994. ftp://nonmem.iconplc.com/Public/ nonmem712/README - 7.1.2.pdf (accessed 5 March 2010).
14. Karlsson M.O., Jonsson E.N., Wiltse C.G., et al. Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients. J Pharmacokinet Biopharm 1998;26:207-246 (Pubitemid 28496599)
15. Brendel K., Comets E., Laffont C., et al. Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide. Pharm Res 2006;23:2036-2049
16. Anderson B.J., Woollard G.A., Holford N.H. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 2000;50:125-134 (Pubitemid 30612030)
17. Kaushal R., Bates D.W., Landrigan C., et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-2120 (Pubitemid 32367829)
18. Ghaleb M.A., Barber N., Franklin B.D., et al. The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child 2010;95:113-118
19. Kneen R., Jakka S., Mithyantha R., et al. The management of infants and children treated with aciclovir for suspected viral encephalitis. Arch Dis Child 2010;95:100-106
20. Janoly-Dumenyl A., Bleyza N., Richard I., et al. Intérèt de l'individualisation des posologies de vancomycine par une méhode bayésienne dans un service de réanimation néonatale. J Pharm Clin 2003;22:95-100. (Pubitemid 36935078)
21. Wong E., Taylor Z., Thompson J., et al. A simplified gentamicin dosing chart is quicker and more accurate for nurse verification than the BNFc. Arch Dis Child 2009;94:542-545
22. Rudd P.T., Hughes E.A., Placzek M.M., et al. Reference ranges for plasma creatinine during the first month of life. Arch Dis Child 1983;58:212-215 (Pubitemid 13159714)
23. Finney H., Newman D.J., Thakkar H., et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000;82:71-75 (Pubitemid 30305737)
24. Venkatesh M.P., Placencia F., Weisman L.E. Coagulase-negative staphylococcal infections in the neonate and child: an update. Semin Pediatr Infect Dis 2006;17:120-127 (Pubitemid 44278616)
25. Bingen E., Mariani-Kurkdjian P., Nebbad B. [Optimal vancomycin serum level in Staphylococcus aureus infections?]. Med Mal Infect 2006;36:439-442
26. Rybak M., Lomaestro B., Rotschafer J.C., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98.